Body, J.-J. http://orcid.org/0000-0002-9165-1444
Marin, F. http://orcid.org/0000-0003-2899-9840
Kendler, D.L. http://orcid.org/0000-0001-7679-3965
Zerbini, C.A.F. http://orcid.org/0000-0001-6269-2354
López-Romero, P. http://orcid.org/0000-0001-9066-1109
Möricke, R. http://orcid.org/0000-0001-8830-9974
Casado, E. http://orcid.org/0000-0001-8839-6430
Fahrleitner-Pammer, A. http://orcid.org/0000-0002-5590-0888
Stepan, J.J. http://orcid.org/0000-0003-1541-8306
Lespessailles, E. http://orcid.org/0000-0003-1009-8518
Minisola, S. http://orcid.org/0000-0001-6525-0439
Geusens, P. http://orcid.org/0000-0002-7547-9146
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 25 February 2020
Accepted: 11 May 2020
First Online: 30 May 2020
Compliance with ethical standards
:
: Jean-Jacques Body: consultant fees from Amgen, Sandoz, and UCB; research support from Lilly. Fernando Marin: employee, Lilly. David L. Kendler: honoraria, research grants, and/or consultant fees from Amgen, Lilly, Radius, and Pfizer. Cristiano A.F. Zerbini: research support from Lilly. Pedro López-Romero: employee, Lilly. Rüdiger Möricke: none. Enrique Casado: speaker and/or consultant fees from Amgen, Lilly, UCB, and Theramex. Astrid Fahrleitner-Pammer: speaker fees from Amgen, Alexion, BMS, Lilly, Fresenius, Sandoz, Shire, and UCB. Jan J. Stepan: none. Eric Lespessailles: speaker and consultant fees from Amgen, Expanscience, Lilly, and MSD; research grants from Abbvie, Amgen, Lilly, MSD, and UCB. Salvatore Minisola: speaker and/or consultant fees from Abiogen, Amgen, DiaSorin, Lilly, Italfarmaco, Fujii, MSD, and Takeda. Piet Geusens: consultant and/or speaker fees from Lilly, and research support from Pfizer, Abbott, Lilly, Amgen, MSD, Roche, UCB, BMS, Mylan, and Novartis.